NCT02311218

Brief Summary

In February 2013, 44 healthy adults was recruited and randomized to daily intake of lozenges with or without Lactobacillus reuteri strains DSM 17938 and PTA 5289 for 12 weeks. The effect of these Lactobacillus reuteri strains on the oral microbial composition was monitored before, after 4, 8 and 12 weeks and after 1 and 6 months after exposure was completed. For this purpose saliva and tooth plaque was collected. Of 44 included subjects, 41 completed the study. The used Lactobacillus reuteri containing lozenges are commercially available and identical placebo lozenges was obtained from the manufacturer. The study product was well tolerated with no observed side effects. Compliance was excellent. The investigators' primary outcome was to determine whether daily intake of Lactobacillus reuteri strains DSM 17938 and PTA 5289 for 12 weeks alters the tooth colonizing bacterial plaque composition determined by a multiplex sequencing technique. Effects are put in relation to general knowledge on bacterial profiles associated with risk to develop dental caries and periodontitis.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Mar 2013

Shorter than P25 for phase_2

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

November 23, 2014

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 8, 2014

Completed
Last Updated

December 8, 2014

Status Verified

November 1, 2014

Enrollment Period

5 months

First QC Date

November 23, 2014

Last Update Submit

December 4, 2014

Conditions

Keywords

oral, microbiota, lactobacillus reuteri,

Outcome Measures

Primary Outcomes (1)

  • Change in oral bacteria biofilm composition after 12-week supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289

    The change in bacteria colonizing the oral cavity after 12 weeks treatment with L. reuteri is analyzed

    Baseline, after 4, 8 and 12 week treatment, and 1 and 6 months after treatment has terminated

Study Arms (2)

Test group with L. reuteri

ACTIVE COMPARATOR

Subjects in the test group take one Lactobacillus reuteri DSM 17938 and PTA 5289 containing lozenge in the morning and one in the evening.

Dietary Supplement: Lactobacillus reuteri DSM 17938 and PTA 5289

Placebo group without L. reuteri

PLACEBO COMPARATOR

Subjects in the placebo group take one placebo lozenges with same look, taste and smell as the test lozenge but lacking the Lactobacillii the morning and one in the evening.

Dietary Supplement: Placebo

Interventions

Subjects in the test group are given one lozenges with Lactobacillus reuteri DSM 17938 and PTA 5289 in the morning and one in the evening

Test group with L. reuteri
PlaceboDIETARY_SUPPLEMENT

Placebo lozenges with no Lactobacillus reuteri DSM 17938 and PTA 5289

Placebo group without L. reuteri

Eligibility Criteria

Age25 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult,
  • healthy,
  • no antibiotic treatment and no intake of probiotic products latest 3 months

You may not qualify if:

  • Acute or chronic disease at recruitment, medication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Romani Vestman N, Chen T, Lif Holgerson P, Ohman C, Johansson I. Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial. PLoS One. 2015 May 6;10(5):e0125812. doi: 10.1371/journal.pone.0125812. eCollection 2015.

MeSH Terms

Conditions

Dental Plaque

Condition Hierarchy (Ancestors)

Dental DepositsTooth DiseasesStomatognathic Diseases

Study Officials

  • Ingegerd Johansson, Professor

    Umea university, Sweden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 23, 2014

First Posted

December 8, 2014

Study Start

March 1, 2013

Primary Completion

August 1, 2013

Study Completion

August 1, 2013

Last Updated

December 8, 2014

Record last verified: 2014-11